All companies
Visit website
ROSE DIAGNOSTICS
OperatingROSE Diagnostics, Inc.
Healthcare · Technology · Founded 2023
Revolutionizing cancer biopsies with point-of-care solutions
Latest valuation ⓘ
$15.0M
Total raised
$0
Across 1 round since 2024
Latest share price
$28.84
Reg CF Offering (2024) offering price
Financials
FY2022–FY2023 · from SEC filings · hover any figure for its source$0
2022
$0
−$64K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$63,761
Taxes paid
$0
$0
Balance sheet
Cash
$0
$5,792
Accounts receivable
$0
$0
Total assets
$0
$5,792
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Fundraising history
Raised $0 / $1.2M
Reg CF annual-report compliance
Delinquent
Filed 0 of 2 annual reports (FY2024–FY2025)
Missing: 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0002027716Share price $28.84
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.